This Article Full Text Full Text (PDF) All Versions of this Article: 38/7/2150    most recent STROKEAHA.106.481218v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, L. H. Articles by Chopp, M. Search for Related Content PubMed PubMed Citation Articles by Shen, L. H. Articles by Chopp, M. Related Collections Other Stroke Treatment - Medical

(Stroke. 2007;38:2150.)
© 2007 American Heart Association, Inc.

Original Contributions

One-Year Follow-Up After Bone Marrow Stromal Cell Treatment in Middle-Aged Female Rats With Stroke

Li Hong Shen, MD, PhD; Yi Li, MD; Jieli Chen, MD; Yisheng Cui, MD; Chunling Zhang, BS; Alissa Kapke, MS; Mei Lu, PhD; Smita Savant-Bhonsale, PhD Michael Chopp, PhD

From the Departments of Neurology (L.H.S., Y.L., J.C., Y.C., C.Z., M.C.) and of Biostatistics and Research Epidemiology (A.K., M.L.), Henry Ford Hospital, Detroit, Mich; Theradigm Inc (S.S.-B.), Baltimore, Md; and the Department of Physics (M.C.), Oakland University, Rochester, Mich.

Correspondence to Michael Chopp, PhD, Department of Neurology, Henry Ford Hospital, E&R 3056, 2799 W Grand Blvd, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu

Background and Purpose— We sought to evaluate the long-term effects of bone marrow stromal cell (BMSC) treatment on retired breeder rats with stroke.

Methods— Female retired breeder rats were subjected to 2-hour middle cerebral artery occlusion (MCAO) followed by an injection of 2x10⁶ male BMSCs (n=8) or phosphate-buffered saline (n=11) into the ipsilateral internal carotid artery at 1 day after stroke. The rats were humanely killed 1 year later. Functional tests, in situ hybridization, and histochemical and immunohistochemical staining were performed.

Results— Significant recovery of neurological deficits was found in BMSC-treated rats beginning 2 weeks after cell injection compared with control animals. The beneficial effects of cell transplantation persisted for at least 1 year (P<0.01). In situ hybridization for the Y chromosome showed that donor cells survived in the brains of recipient rats, among which 22.3±1.95% of cells expressed the astrocyte marker glial fibrillary acidic protein, 16.8±2.13% expressed the neuronal marker microtubule-associated protein 2, and 5.5±0.42% and <1% of cells colocalized with the microglial marker IB4 and the endothelial cell marker von Willebrand factor, respectively. Only very few BMSCs, however, were found in peripheral organs such as the heart, lung, liver, spleen, and kidney in recipient rats. BMSCs significantly reduced axonal loss (P<0.01), the thickness of the lesion scar wall (P<0.01), and the number of Nogo-A–positive cells (P<0.05) along the scar border; meanwhile, synaptophysin expression (P<0.05) was significantly increased in BMSC-treated ischemic brains compared with control untreated brains.

Conclusions— The beneficial effects of BMSCs on ischemic brain tissue persisted for at least 1 year. Most surviving BMSCs were present in the ischemic brain, but very few were found in other organs. The long-term improvement in functional outcome may be related to the structural and molecular changes induced by BMSCs.

Key Words: bone marrow stromal cells • middle cerebral artery occlusion • follow-up studies • Y chromosome • axonal restoration

This article has been cited by other articles:

				R. Guzman, A. De Los Angeles, S. Cheshier, R. Choi, S. Hoang, J. Liauw, B. Schaar, and G. Steinberg Intracarotid Injection of Fluorescence Activated Cell-Sorted CD49d-Positive Neural Stem Cells Improves Targeted Cell Delivery and Behavior After Stroke in a Mouse Stroke Model Stroke, April 1, 2008; 39(4): 1300 - 1306. [Abstract] [Full Text] [PDF]